Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Malignant Lymphoma

  Free Subscription


Articles published in J Am Acad Dermatol

Retrieve available abstracts of 57 articles:
HTML format



Single Articles


    July 2022
  1. QUERFELD C, Kim YH, Guitart J, Scarisbrick J, et al
    Use of chlormethine 0.04% gel for mycosis fungoides after treatment with topical chlormethine 0.02% gel: A phase 2 extension study.
    J Am Acad Dermatol. 2022;87:209-211.
    PubMed    


    June 2022
  2. O'DONNELL M, Zaya R, Correia E, Krishnasamy S, et al
    Disease characteristics, prognosis, and response to therapy in patients with large-cell transformed mycosis fungoides: A single-center retrospective study.
    J Am Acad Dermatol. 2022;86:1285-1292.
    PubMed     Abstract available


  3. SUH KS, Jang MS, Jung JH, Kwon DI, et al
    Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: A 29-year review.
    J Am Acad Dermatol. 2022;86:1275-1284.
    PubMed     Abstract available


  4. CHOI J, Sutaria N, Roh YS, Bordeaux Z, et al
    Racial and ethnic disparities in inpatient health care utilization for mycosis fungoides: A cross-sectional analysis of the 2012-2017 National Inpatient Sample.
    J Am Acad Dermatol. 2022;86:1408-1410.
    PubMed    


  5. JUNG JM, Yoo H, Lim DJ, Won CH, et al
    Clinicoprognostic implications of head and neck involvement by mycosis fungoides: A retrospective cohort study.
    J Am Acad Dermatol. 2022;86:1258-1265.
    PubMed     Abstract available


    May 2022
  6. BESCH-STOKES JG, Costello CM, Severson KJ, Bhullar P, et al
    Primary cutaneous CD4(+) small/medium T-cell lymphoproliferative disorder: Diagnosis and management.
    J Am Acad Dermatol. 2022;86:1167-1169.
    PubMed    


    April 2022
  7. CHERAGHLOU S, Ugwu N, Girardi M
    Treatment at high-volume facilities is associated with improved overall survival for patients with cutaneous B-cell lymphoma.
    J Am Acad Dermatol. 2022 Apr 24. pii: S0190-9622(22)00698.
    PubMed    


  8. ERRICHETTI E, Geller S, Zalaudek I, Longo C, et al
    Dermatoscopy of nodular/plaque-type primary cutaneous T- and B-cell lymphomas: A retrospective comparative study with pseudolymphomas and tumoral/inflammatory mimickers by the International Dermoscopy Society.
    J Am Acad Dermatol. 2022;86:774-781.
    PubMed     Abstract available


  9. NAWAR T, Elsayad K, Muller EC, Rolf D, et al
    Quality of life in patients with mycosis fungoides and Sezary syndrome undergoing low-dose total skin electron beam therapy with or without maintenance therapy.
    J Am Acad Dermatol. 2022;86:889-891.
    PubMed    


  10. CARITI C, Quaglino P, Lupia T, Novelli M, et al
    Infections in Sezary syndrome: A retrospective cohort study of 113 patients.
    J Am Acad Dermatol. 2022;86:943-946.
    PubMed    


    March 2022
  11. MAGHFOUR J, Gill F, Olson J, Guido N, et al
    Association of Airborne Toxins with Geographic Clustering of Cutaneous T Cell Lymphoma in Louisiana.
    J Am Acad Dermatol. 2022 Mar 7. pii: S0190-9622(22)00378.
    PubMed    


    January 2022
  12. ABRAHAM J, Wei G, Desai SR, Seminario-Vidal L, et al
    A cross-sectional analysis of quality-of-life in skin of color patients with cutaneous t-cell lymphoma: an exploratory study.
    J Am Acad Dermatol. 2022 Jan 24. pii: S0190-9622(22)00100.
    PubMed    


  13. BELLINATO F, Gisondi P, Girolomoni G
    Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: A systematic review with meta-analysis.
    J Am Acad Dermatol. 2022;86:86-96.
    PubMed     Abstract available


  14. BEHBAHANI S, Yeh CJ, Fernandez JM, Chen ST, et al
    Gender differences in clinical presentation, treatment, and outcomes in mycosis fungoides.
    J Am Acad Dermatol. 2022;86:174-177.
    PubMed    


    December 2021
  15. ROLF D, Elsayad K, Eich HT
    Ultra-hypofractionated low-dose total skin electron beam followed by maintenance therapy: Preliminary findings from a prospective open-label study.
    J Am Acad Dermatol. 2021;85:1601-1603.
    PubMed    


    November 2021
  16. FERRIER A, Soong L, Alabdulsalam A, Kunimoto B, et al
    Diagnosis of gamma/delta mycosis fungoides requires longitudinal clinical observation.
    J Am Acad Dermatol. 2021;85:1352-1353.
    PubMed    


  17. GOYAL N, O'Leary D, Rubin N, Bohjanen K, et al
    Localization patterns and survival of extranodal natural killer/T-cell lymphomas in the United States: A population-based study of 945 cases.
    J Am Acad Dermatol. 2021;85:1318-1321.
    PubMed    


  18. OH Y, Stoll JR, Moskowitz A, Pulitzer M, et al
    Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sezary syndrome. Part II: Prognosis and management.
    J Am Acad Dermatol. 2021;85:1093-1106.
    PubMed     Abstract available


  19. STOLL JR, Willner J, Oh Y, Pulitzer M, et al
    Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sezary syndrome. Part I: Clinical and histologic features and diagnosis.
    J Am Acad Dermatol. 2021;85:1073-1090.
    PubMed     Abstract available


    October 2021
  20. LEWITT TM, Walker CJ, Espinosa ML, Chung C, et al
    Cutaneous T-Cell Lymphoma and Pregnancy: Great Uncertainty and an Appeal for Prospective Clinical Research.
    J Am Acad Dermatol. 2021 Oct 29. pii: S0190-9622(21)02725.
    PubMed    


  21. SEVERSON KJ, Cumsky HJL, Brumfiel CM, Janeczek MC, et al
    Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study.
    J Am Acad Dermatol. 2021;85:969-971.
    PubMed    


  22. KURAITIS D, McBurney E, Boh E
    Utility of clonal T-cell rearrangement study in the diagnosis of early mycosis fungoides.
    J Am Acad Dermatol. 2021;85:1040-1042.
    PubMed    


    September 2021
  23. ROZENBAUM D, Tung J, Xue Y, Hoang MP, et al
    Skin biopsy in the diagnosis of intravascular lymphoma: A retrospective diagnostic accuracy study.
    J Am Acad Dermatol. 2021;85:665-670.
    PubMed     Abstract available


  24. XUE R, Elbendary A, Liu H, Chen Y, et al
    Hydroa vacciniforme-like lymphoma: Clinicopathologic description, treatment, and outcome.
    J Am Acad Dermatol. 2021;85:752-755.
    PubMed    


    August 2021
  25. SAMIE FH
    JAAD Game Changers *: Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides.
    J Am Acad Dermatol. 2021;85:537.
    PubMed    


    July 2021
  26. GOYAL A, O'Leary D, Foreman RK, Duncan LM, et al
    Assessing the diagnosis of "primary cutaneous mantle cell lymphoma": A systematic review and population-based analysis.
    J Am Acad Dermatol. 2021 Jul 31. pii: S0190-9622(21)02201.
    PubMed    


  27. TUNG JK, Rozenbaum D, Rrapi R, Chand S, et al
    Skin biopsy in the diagnosis of intravascular lymphoma: a retrospective diagnostic accuracy study.
    J Am Acad Dermatol. 2021 Jul 24. pii: S0190-9622(21)02168.
    PubMed    


  28. ENZAN N, Kitadate A, Kono M
    Comment on skin biopsies for diagnosing intravascular lymphoma: a retrospective study of diagnostic accuracy.
    J Am Acad Dermatol. 2021 Jul 23. pii: S0190-9622(21)02167.
    PubMed    


  29. NEWMAN NB, Patel CG, Ding GX, Zic JA, et al
    Prospective observational trial of low-dose skin electron beam therapy in mycosis fungoides using a rotational technique.
    J Am Acad Dermatol. 2021;85:121-127.
    PubMed     Abstract available


    March 2021
  30. KARTAN S, Shalabi D, O'Donnell M, Alpdogan SO, et al
    Response to topical corticosteroid monotherapy in mycosis fungoides.
    J Am Acad Dermatol. 2021;84:615-623.
    PubMed     Abstract available


    January 2021
  31. JUNG JM, Na HM, Won CH, Chang SE, et al
    Cutaneous Epstein-Barr Virus-Positive Diffuse Large B-cell Lymphoma, not otherwise specified: A systematic review and comparative analysis with Epstein-Barr Virus-negative, leg type.
    J Am Acad Dermatol. 2021 Jan 30. pii: S0190-9622(21)00248.
    PubMed    


  32. JU HJ, Han JH, Kim MS, Lee SH, et al
    The long-term risk of lymphoma and skin cancer was not increased after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo.
    J Am Acad Dermatol. 2021 Jan 25. pii: S0190-9622(21)00224.
    PubMed     Abstract available


  33. MALACHOWSKI SJ, Moy A, Messina J, Chen YA, et al
    Mapping Cutaneous T-Cell Lymphoma in the State of Florida: a Retrospective Exploratory Spatial Analysis of Incidence Patterns.
    J Am Acad Dermatol. 2021 Jan 18. pii: S0190-9622(21)00190.
    PubMed    


    December 2020
  34. WEINER DM, Durgin JS, Wysocka M, Rook AH, et al
    The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part II, Current and Future Approaches.
    J Am Acad Dermatol. 2020 Dec 19. pii: S0190-9622(20)33186.
    PubMed     Abstract available


  35. DURGIN JS, Weiner DM, Wysocka M, Rook AH, et al
    The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part I, Pathways and Targets for Immune Restoration and Tumor Eradication.
    J Am Acad Dermatol. 2020 Dec 19. pii: S0190-9622(20)33187.
    PubMed     Abstract available


  36. RAMACHANDRAN V, Park KE, Loya A, Duvic M, et al
    Second primary malignancies in blastic plasmacytoid dendritic cell neoplasm: A national database study.
    J Am Acad Dermatol. 2020;83:1786-1789.
    PubMed    


    November 2020
  37. SCHACHTER O, Tabibian-Keissar H, Debby A, Segal O, et al
    Evaluation of the polymerase chain reaction-based T-cell receptor beta clonality test in the diagnosis of early mycosis fungoides.
    J Am Acad Dermatol. 2020;83:1400-1405.
    PubMed     Abstract available


    August 2020
  38. GOYAL A, O'Leary D, Goyal K, Patel K, et al
    Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer: a systematic review and meta-analysis.
    J Am Acad Dermatol. 2020 Aug 18. pii: S0190-9622(20)32444.
    PubMed     Abstract available


  39. GELLER S, Lebowitz E, Pulitzer MP, Horwitz SM, et al
    Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sezary syndrome: Retrospective analysis of 157 patients from a referral cancer center.
    J Am Acad Dermatol. 2020;83:430-439.
    PubMed     Abstract available


  40. GOYAL A, O'Leary D, Goyal K, Rubin N, et al
    Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
    J Am Acad Dermatol. 2020;83:404-411.
    PubMed     Abstract available


  41. ALMUKHTAR R, Gill F, Soine R, McBurney E, et al
    Gender differences in the risk of secondary malignancies in patients with mycosis fungoides and Sezary syndrome.
    J Am Acad Dermatol. 2020;83:647-648.
    PubMed    


    July 2020
  42. MUNIESA C, Domingo-Domenech E, Fornons-Servent R, Penate Y, et al
    SYSTEMIC RITUXIMAB FOR THE TREATMENT OF THE INDOLENT FORMS OF PRIMARY CUTANEOUS B-CELL LYMPHOMAS: data from the Spanish Primary Cutaneous Lymphoma Registry.
    J Am Acad Dermatol. 2020 Jul 16. pii: S0190-9622(20)32192.
    PubMed    


  43. SONG A, Gochoco A, Zhan T, Sahu J, et al
    A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life.
    J Am Acad Dermatol. 2020;83:78-85.
    PubMed     Abstract available


    May 2020
  44. ELLIS A, Christensen LF, Sharma T, Meyerson H, et al
    CD30 positive Leukemic Cutaneous T Cell Lymphoma.
    J Am Acad Dermatol. 2020 May 10. pii: S0190-9622(20)30841.
    PubMed    


  45. LAKE E
    JAAD Game Changers*: Risk of venous thromboembolism in patients with mycosis fungoides and parapsoriasis: A Danish nationwide population-based cohort study.
    J Am Acad Dermatol. 2020;82:1274.
    PubMed    


    April 2020
  46. GAO C, McCormack CJ, van der Weyden C, Twigger R, et al
    The importance of differentiating between Mycosis Fungoides with CD30 positive large cell transformation and Mycosis Fungoides with co-existent primary cutaneous Anaplastic Large Cell Lymphoma.
    J Am Acad Dermatol. 2020 Apr 22. pii: S0190-9622(20)30688.
    PubMed    


  47. ZIC JA, Ai W, Akilov OE, Carter JB, et al
    (United States Cutaneous Lymphoma Consortium) Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic.
    J Am Acad Dermatol. 2020 Apr 16. pii: S0190-9622(20)30662.
    PubMed    


  48. YUKI A, Ansai O, Abe R
    CADM1 expression of mast cells in mycosis fungoides.
    J Am Acad Dermatol. 2020;82:e143-e144.
    PubMed    


  49. ZHANG S, Wang T, Liu Y
    CADM1: A molecule worth investigating in mycosis fungoides and Sezary syndrome.
    J Am Acad Dermatol. 2020;82:e141-e142.
    PubMed    


    March 2020
  50. ELSTON DM
    Letter from the editor: Dupilumab and Cutaneous T-cell Lymphoma.
    J Am Acad Dermatol. 2020 Mar 27. pii: S0190-9622(20)30471.
    PubMed    


  51. ESPINOSA ML, Nguyen MT, Aguirre AS, Martinez-Escala ME, et al
    Progression of Cutaneous T-Cell Lymphoma after dupilumab: Case review of 7 patients.
    J Am Acad Dermatol. 2020 Mar 27. pii: S0190-9622(20)30470.
    PubMed    


  52. DELOST GR, Giesey RL, Christensen LF, Scott J, et al
    Cutaneous lymphomas in adolescents and young adults: Clinical spectrum and physician-reported and patient-reported outcomes.
    J Am Acad Dermatol. 2020;82:751-753.
    PubMed    


  53. GOYAL A, O'Leary D, Goyal K, Rubin N, et al
    Increased risk of second primary malignancies in patients with mycosis fungoides: A single-center cohort study.
    J Am Acad Dermatol. 2020;82:736-738.
    PubMed    


    January 2020
  54. PAVLOTSKY F, Hodak E, Dawood M, Barzilai A, et al
    Stage IA mycosis fungoides should be treated until proven otherwise.
    J Am Acad Dermatol. 2020;82:e19-e20.
    PubMed    


  55. BISHNOI A, Kumar S, Vinay K
    Stage IA mycosis fungoides: When not to treat?
    J Am Acad Dermatol. 2020;82:e17-e18.
    PubMed    


  56. FLAMM A, Alcocer VM, Kazlouskaya V, Kwon EJ, et al
    Histopathologic features distinguishing secondary syphilis from its mimickers.
    J Am Acad Dermatol. 2020;82:156-160.
    PubMed     Abstract available


    November 2019
  57. DESTEFANO CB, Desale S, Fernandez SJ, Shenoy AG, et al
    The impact of environmental ultraviolet exposure on the clinical course of mycosis fungoides.
    J Am Acad Dermatol. 2019;81:1074-1077.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: